Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
Open Access
- 11 March 2010
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11 (1) , 40
Abstract
Multiple lines of evidence suggest that genetic factors contribute to stroke recovery. The matrix metalloproteinases -2 (MMP-2) and -9 (MMP-9) are modulators of extracellular matrix components, with important regulatory functions in the Central Nervous System (CNS). Shortly after stroke, MMP-2 and MMP-9 have mainly damaging effects for brain tissue. However, MMPs also have a beneficial activity in angiogenesis and neurovascular remodelling during the delayed neuroinflammatory response phase, thus possibly contributing to stroke functional recovery.Keywords
This publication has 24 references indexed in Scilit:
- Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemiaNeuroscience, 2009
- Multiphasic roles for matrix metalloproteinases after strokeCurrent Opinion in Pharmacology, 2008
- APOE ε3 Gene Transfer Attenuates Brain Damage after Experimental StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Matrix Metalloproteinase-9 Gene Knock-out Protects the Immature Brain after Cerebral Hypoxia–IschemiaJournal of Neuroscience, 2007
- Decreased expression of brain‐derived neurotrophic factor in BDNF+/− mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental strokeJournal of Neuroscience Research, 2006
- Family history and stroke outcome in a bi-ethnic, population-based stroke surveillance studyBMC Neurology, 2005
- A Highly Specific Inhibitor of Matrix Metalloproteinase-9 Rescues Laminin from Proteolysis and Neurons from Apoptosis in Transient Focal Cerebral IschemiaThe Journal of Neuroscience, 2005
- Family History in Ischemic Stroke Before 70 Years of AgeStroke, 2005
- Profiles of Matrix Metalloproteinases, Their Inhibitors, and Laminin in Stroke PatientsStroke, 2003
- VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemiaJournal of Clinical Investigation, 2003